IGF-1 LR3

MuscleRecovery

IGF-1 LR3 is a modified, longer-acting analogue of insulin-like growth factor 1 used in laboratory research into cell growth, nutrient signaling, and tissue repair.

What does it do?

Supports muscle protein synthesis and lean-tissue repair after training
Helps shuttle nutrients into muscle cells, which can improve recovery and fullness
May aid body composition by supporting muscle while the body uses more fuel
Can speed tissue repair signaling after hard sessions or injury stress
Studies and user protocols link it to improved recovery, not steroid-like mass overnight

How does it work?

Acts as a long-acting IGF-1 analog that stays active longer than natural IGF-1
Binds IGF-1 receptors on muscle and other tissues to turn on growth-and-repair pathways
Has reduced binding to IGF-binding proteins, so more of it stays “free” and usable
Activates PI3K/Akt/mTOR signaling, which tells cells to build protein and recover
Mimics some insulin-like effects, increasing glucose uptake into cells (this is also why blood sugar can drop)

How it's typically administered

Subcutaneous injectionmost common route in research
Intramuscular injectionused in some protocols; higher risk
Topical serum or creamnot effective systemically
Nasal sprayunreliable absorption; little research support
Oral capsulesnot bioavailable orally

How it's typically dosed

Most common dose20–50 mcg
FrequencyPer day
Cycle duration4-week cycles

BackAll Muscle and Recovery Peptides Full peptide list

For educational purposes only. Consult a qualified healthcare provider before considering any peptide therapy.